Showing results (171-180 of 527) with videos related to
Sort By:
Pageof 53
Biorxiv : the Preprint Server for Biology|November 24, 2025
Human Coronavirus HKU1 Neutralizing Monoclonal Antibodies Target Diverse Epitopes Within and Around the TMPRSS2 Receptor Binding SiteLingshu Wang, Jeswin Joseph, Sheena Vasquez, et al.Virology|June 5, 2019
A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virusYouri Lee, Eun-Ju Ko, Ki-Hye Kim, et al.Molecular Immunology|March 10, 2022
Functional reconstitution of the MERS CoV receptor binding motifLakshminarasaiah Uppalapati, Anna Roitburd-Berman, Yael Weiss-Ottolenghi, et al.Nature Communications|March 18, 2023
Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F proteinPatrick O Byrne, Brian E Fisher, David R Ambrozak, et al.NPJ Vaccines|October 26, 2022
CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccinesSean A Nelson, Katherine A Richards, Maryah A Glover, et al.Frontiers in Immunology|August 30, 2018
Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine CytomegalovirusKaitlyn M Morabito, Tracy J Ruckwardt, Erez Bar-Haim, et al.Plos Pathogens|December 7, 2011
Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected miceTracy J Ruckwardt, Allison M W Malloy, Emma Gostick, et al.Journal of Virology|August 25, 2017
Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV FXiang Liu, Bo Liang, Joan Ngwuta, et al.Journal of Virology|August 24, 2007
Induction of epitope-specific neutralizing antibodies against West Nile virusTheodore Oliphant, Grant E Nybakken, S Kyle Austin, et al.Plos One|November 5, 2010
Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)Laurence Peiperl, Cecilia Morgan, Zoe Moodie, et al.Pageof 53